Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2530029rdf:typepubmed:Citationlld:pubmed
pubmed-article:2530029lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:2530029lifeskim:mentionsumls-concept:C0521009lld:lifeskim
pubmed-article:2530029lifeskim:mentionsumls-concept:C0007121lld:lifeskim
pubmed-article:2530029lifeskim:mentionsumls-concept:C0027780lld:lifeskim
pubmed-article:2530029lifeskim:mentionsumls-concept:C0009566lld:lifeskim
pubmed-article:2530029lifeskim:mentionsumls-concept:C2348070lld:lifeskim
pubmed-article:2530029lifeskim:mentionsumls-concept:C0205171lld:lifeskim
pubmed-article:2530029lifeskim:mentionsumls-concept:C0205179lld:lifeskim
pubmed-article:2530029pubmed:issue5lld:pubmed
pubmed-article:2530029pubmed:dateCreated1989-11-28lld:pubmed
pubmed-article:2530029pubmed:abstractTextIn 40 patients with bacterial bronchopulmonary complications during polychemotherapy for advanced bronchogenic carcinoma, once-daily netilmicin (4.5 mg/kg every 24 h) brought about complete resolution of the infective process in 90% of the cases and eradication of the responsible pathogen in 82%. This result must be considered good in view of the patients' precarious condition due to their advanced neoplastic disease.lld:pubmed
pubmed-article:2530029pubmed:languageitalld:pubmed
pubmed-article:2530029pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2530029pubmed:citationSubsetIMlld:pubmed
pubmed-article:2530029pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2530029pubmed:statusMEDLINElld:pubmed
pubmed-article:2530029pubmed:monthSeplld:pubmed
pubmed-article:2530029pubmed:issn0009-9074lld:pubmed
pubmed-article:2530029pubmed:authorpubmed-author:ZubianiMMlld:pubmed
pubmed-article:2530029pubmed:authorpubmed-author:GagliardoGGlld:pubmed
pubmed-article:2530029pubmed:authorpubmed-author:FranchiniFFlld:pubmed
pubmed-article:2530029pubmed:authorpubmed-author:RanieriGGlld:pubmed
pubmed-article:2530029pubmed:authorpubmed-author:SalvatiFFlld:pubmed
pubmed-article:2530029pubmed:authorpubmed-author:MarianiM AMAlld:pubmed
pubmed-article:2530029pubmed:authorpubmed-author:SignoriEElld:pubmed
pubmed-article:2530029pubmed:authorpubmed-author:NotaroF MFMlld:pubmed
pubmed-article:2530029pubmed:authorpubmed-author:AquiliniMMlld:pubmed
pubmed-article:2530029pubmed:authorpubmed-author:LuciforaVVlld:pubmed
pubmed-article:2530029pubmed:issnTypePrintlld:pubmed
pubmed-article:2530029pubmed:day15lld:pubmed
pubmed-article:2530029pubmed:volume130lld:pubmed
pubmed-article:2530029pubmed:ownerNLMlld:pubmed
pubmed-article:2530029pubmed:authorsCompleteYlld:pubmed
pubmed-article:2530029pubmed:pagination267-70lld:pubmed
pubmed-article:2530029pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2530029pubmed:meshHeadingpubmed-meshheading:2530029-...lld:pubmed
pubmed-article:2530029pubmed:meshHeadingpubmed-meshheading:2530029-...lld:pubmed
pubmed-article:2530029pubmed:meshHeadingpubmed-meshheading:2530029-...lld:pubmed
pubmed-article:2530029pubmed:meshHeadingpubmed-meshheading:2530029-...lld:pubmed
pubmed-article:2530029pubmed:meshHeadingpubmed-meshheading:2530029-...lld:pubmed
pubmed-article:2530029pubmed:meshHeadingpubmed-meshheading:2530029-...lld:pubmed
pubmed-article:2530029pubmed:meshHeadingpubmed-meshheading:2530029-...lld:pubmed
pubmed-article:2530029pubmed:meshHeadingpubmed-meshheading:2530029-...lld:pubmed
pubmed-article:2530029pubmed:meshHeadingpubmed-meshheading:2530029-...lld:pubmed
pubmed-article:2530029pubmed:meshHeadingpubmed-meshheading:2530029-...lld:pubmed
pubmed-article:2530029pubmed:meshHeadingpubmed-meshheading:2530029-...lld:pubmed
pubmed-article:2530029pubmed:year1989lld:pubmed
pubmed-article:2530029pubmed:articleTitle[Netilmicin in single daily doses for the bacterial bronchopulmonary complications in patients with advanced bronchogenic carcinoma].lld:pubmed
pubmed-article:2530029pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2530029pubmed:publicationTypeEnglish Abstractlld:pubmed